Get the Stockscreener App
0.535
5.71%
0.0289
Pre-market:
.55
0.015
+2.80%
Biomerica Inc Stock (BMRA) Forecast
The Biomerica Inc (BMRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.3641, representing a +154.97% increase from the current price of $0.535. The highest analyst price target is $1.5869, and the lowest is $1.1413.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BMRA Price Target
Average 11.19
(+1,991% Upside)
Is Biomerica Inc (BMRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.53 | Neutral |
| STOCH(9,6) | 13.98 | Buy |
| STOCHRSI(14) | 30.11 | Neutral |
| MACD(12,26) | 0.0379 | Sell |
| ADX(14) | 45.74 | Buy |
| William %R | -66.98 | Neutral |
| CCI(14) | -32.31 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5574
Sell
|
0.5276
Buy
|
| MA20 |
0.5212
Buy
|
0.5065
Buy
|
| MA50 |
0.4005
Buy
|
0.4388
Buy
|
| MA100 |
0.367
Buy
|
0.4144
Buy
|
| MA200 |
0.4191
Buy
|
0.4913
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, BMRA could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on BMRA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.53 indicates that BMRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 13.98 indicates that BMRA is oversold. This indicates that BMRA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.11 indicates that BMRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 45.74 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -32.31 indicates that BMRA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BMRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Biomerica Inc financial reports and earnings history, Biomerica Inc (BMRA) stock could reach $1.071 by 2030, $0.4758 by 2040 and $1.2233 by 2050. See the projected annual prices until 2050 of the Biomerica Inc stock below:
- Biomerica Inc (BMRA) is expected to reach an average price of $0.2885 in 2035, with a high prediction of $0.2485 and a low estimate of $0.3032. This indicates an $-46.08% rise from the last recorded price of $0.535.
- Biomerica Inc (BMRA) stock is projected to chart a bullish course in 2040, with an average price target of $0.8658, representing an $61.84% surge from its current level. The forecast ranges from a conservative $0.5319 to a sky-high $0.4758.
- Our analysts predict Biomerica Inc (BMRA) to jump -29.21% by 2045, soaring from $0.00135 to an average price of $0.3787, potentially reaching $0.6987. While $0.00135 is the low estimate, the potential upside is significant.
- Biomerica Inc (BMRA) stock is expected to climb by 2050, reaching an average of $1.4035, a $162.33% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.2233 and $1.0919, respectively, highlighting the market's uncertainty.
Biomerica Inc Stock (BMRA) Year by Year Forecast
Biomerica Inc Stock (BMRA) Price Forecast for 2025
Biomerica Inc Stock (BMRA) is expected to reach an average price of $11.19 in 2025, with a high prediction of $21.85 and a low estimate of $0.523. This indicates an +1,991% rise from the last recorded price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $1.30 | $1.1413 | $1.5869 | +142.98% |
| April, 2025 | $5.6117 | $0.523 | $21.85 | +948.91% |
| May, 2025 | $6.4491 | $4.786 | $9.9647 | +1,105% |
| June, 2025 | $5.9164 | $4.9721 | $7.0834 | +1,006% |
| July, 2025 | $4.6382 | $3.4638 | $5.9908 | +766.95% |
| August, 2025 | $7.4755 | $4.7125 | $7.4855 | +1,297% |
| September, 2025 | $7.3929 | $6.6742 | $11.28 | +1,282% |
| October, 2025 | $5.4846 | $4.0946 | $8.3173 | +925.17% |
| November, 2025 | $5.542 | $5.0177 | $6.3433 | +935.89% |
| December, 2025 | $4.0937 | $3.035 | $6.595 | +665.18% |
Biomerica Inc Stock (BMRA) Price Forecast for 2026
The predicted value for Biomerica Inc (BMRA) in 2026 is set at an average of $4.4587. Estimates vary from a peak of $6.8533 to a trough of $2.0641, indicating an +733.40% surge from the present price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.3911 | $3.9481 | $5.9424 | +907.69% |
| February, 2026 | $4.0685 | $4.0485 | $5.9642 | +660.47% |
| March, 2026 | $4.3859 | $3.2772 | $6.4759 | +719.79% |
| April, 2026 | $5.6776 | $4.4102 | $6.8533 | +961.23% |
| May, 2026 | $5.485 | $3.8969 | $5.9369 | +925.23% |
| June, 2026 | $4.1124 | $3.9087 | $5.7924 | +668.66% |
| July, 2026 | $2.3141 | $2.0641 | $4.1867 | +332.54% |
| August, 2026 | $2.8515 | $2.1384 | $3.8315 | +432.98% |
| September, 2026 | $2.5532 | $2.3032 | $3.1388 | +377.23% |
| October, 2026 | $2.7306 | $2.3075 | $3.3519 | +410.38% |
| November, 2026 | $3.3179 | $2.6449 | $3.5779 | +520.17% |
| December, 2026 | $3.3297 | $2.901 | $4.2397 | +522.37% |
Biomerica Inc Stock (BMRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Biomerica Inc (BMRA) is $3.9405, with a high forecast of $6.2483 and a low forecast of $1.6326. This indicates an +636.54% increase from the last price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.697 | $3.627 | $6.2483 | +591.04% |
| February, 2027 | $3.9744 | $3.0257 | $4.2801 | +642.88% |
| March, 2027 | $3.1061 | $2.6361 | $4.0888 | +480.59% |
| April, 2027 | $3.3235 | $2.7292 | $3.4735 | +521.22% |
| May, 2027 | $3.1609 | $2.7122 | $3.6479 | +490.82% |
| June, 2027 | $3.0726 | $2.7239 | $3.5996 | +474.32% |
| July, 2027 | $3.46 | $2.5196 | $3.58 | +546.73% |
| August, 2027 | $3.1074 | $3.0075 | $3.7287 | +480.82% |
| September, 2027 | $2.3691 | $1.6704 | $3.2117 | +342.82% |
| October, 2027 | $1.9865 | $1.9065 | $2.8421 | +271.30% |
| November, 2027 | $1.9939 | $1.8252 | $2.1908 | +272.68% |
| December, 2027 | $2.1732 | $1.6326 | $2.9882 | +306.20% |
Biomerica Inc Stock (BMRA) Price Forecast for 2028
In 2028, Biomerica Inc (BMRA) is projected to reach an average price of $2.3701, with a high projection of $4.379 and a low estimate of $0.3611. This indicates an +343.00% rise from the last price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.593 | $2.1899 | $2.7786 | +384.67% |
| February, 2028 | $3.0503 | $2.4374 | $3.2203 | +470.16% |
| March, 2028 | $2.4321 | $2.0677 | $4.379 | +354.59% |
| April, 2028 | $3.3294 | $2.1757 | $3.3294 | +522.32% |
| May, 2028 | $2.8912 | $2.5388 | $3.3138 | +440.40% |
| June, 2028 | $2.0985 | $2.0985 | $2.9855 | +292.25% |
| July, 2028 | $2.1359 | $1.9029 | $2.3471 | +299.24% |
| August, 2028 | $1.5476 | $1.4833 | $2.2803 | +189.28% |
| September, 2028 | $0.995 | $0.958 | $1.712 | +85.99% |
| October, 2028 | $0.7224 | $0.4481 | $1.1493 | +35.03% |
| November, 2028 | $0.5541 | $0.3611 | $1.0696 | +3.57% |
| December, 2028 | $0.6715 | $0.5385 | $1.0386 | +25.51% |
Biomerica Inc Stock (BMRA) Price Forecast for 2029
The 2029 price forecast for Biomerica Inc Stock (BMRA) is $0.7981 on average, with a high prediction of $1.5675 and a low estimate of $0.0287. This represents an +49.18% increase from the previous price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6532 | $0.5402 | $0.7959 | +22.10% |
| February, 2029 | $0.5006 | $0.3763 | $1.1476 | -6.43% |
| March, 2029 | $0.468 | $0.428 | $0.6993 | -12.53% |
| April, 2029 | $0.1264 | $0.085 | $0.5123 | -76.38% |
| May, 2029 | $0.3571 | $0.0998 | $0.5584 | -33.26% |
| June, 2029 | $0.3545 | $0.2514 | $0.4004 | -33.75% |
| July, 2029 | $0.6918 | $0.3198 | $1.5675 | +29.32% |
| August, 2029 | $0.3936 | $0.2541 | $0.7662 | -26.44% |
| September, 2029 | $0.7709 | $0.2833 | $0.8309 | +44.10% |
| October, 2029 | $0.3903 | $0.3527 | $0.8252 | -27.05% |
| November, 2029 | $0.2503 | $0.2501 | $0.462 | -53.21% |
| December, 2029 | $1.1098 | $0.0287 | $1.1098 | +107.44% |
Biomerica Inc Stock (BMRA) Price Forecast for 2030
Biomerica Inc Stock (BMRA) is expected to reach an average price of $10.17 in 2030, with a high forecast of $20.33 and a low forecast of $0.0168. This signifies an +1,801% surge from the last price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.1226 | $1.2037 | $1.071 | +109.82% |
| February, 2030 | $0.4916 | $0.8287 | $0.9077 | -8.11% |
| March, 2030 | $0.0632 | $0.0168 | $0.3529 | -88.19% |
| April, 2030 | $0.4321 | $0.1582 | $0.2418 | -19.24% |
| May, 2030 | $0.0742 | $0.2086 | $0.2234 | -86.12% |
| June, 2030 | $0.0539 | $0.1839 | $0.0802 | -89.93% |
| July, 2030 | $0.2604 | $0.1663 | $0.1491 | -51.32% |
| August, 2030 | $0.299 | $0.2315 | $0.3044 | -44.12% |
| September, 2030 | $0.1909 | $0.2609 | $0.147 | -64.31% |
| October, 2030 | $0.2576 | $0.0604 | $0.2678 | -51.86% |
| November, 2030 | $0.4927 | $0.1914 | $0.4287 | -7.90% |
| December, 2030 | $3.682 | $1.004 | $20.33 | +588.23% |
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):